FDA Inspection 645186 — IVF Phoenix P.L.L.C.

IVF Phoenix P.L.L.C. — FEI 3003942387

The FDA completed an inspection of IVF Phoenix P.L.L.C. on February 5, 2010 in Scottsdale, AZ. The inspection was classified OAI (Official Action Indicated — objectionable conditions were found and regulatory action is recommended). 4 citations were issued during this inspection. Product area: Biologics.

Inspection Details

Classification
Official Action Indicated (OAI) (OAI)
End Date
February 5, 2010
Fiscal Year
2010
Product Type
Biologics
Project Area
Human Cellular, Tissue, and Gene Therapies
Location
Scottsdale, AZ (United States)

Citations

IDCFRDescription
1221321 CFR 1271.47(a)Testing, screening, donor eligibility procedures
1222521 CFR 1271.47(d)Departures: recording and justifying
1227221 CFR 1271.65(b)(2)Labeled re: biohazard, risks, test results
1228221 CFR 1271.75(d)Donors with risks not determined ineligible